Brief: Surface Oncology Announces Publication Of New Study Demonstrating The Role Of The IL-27 Pathway In Hepatocellular Carcinoma
20/06/2022 16:28
June 20 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY ANNOUNCES PUBLICATION OF NEW STUDY
DEMONSTRATING THE ROLE OF THE IL-27 PATHWAY IN HEPATOCELLULAR
CARCINOMA
* NON-CLINICAL FINDINGS FURTHER SUPPORT POTENTIAL OF SRF388
TO
TREAT PATIENTS SUFFERING FROM LIVER CANCER
Source text for Eikon: ID:nGNX2z3562
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing